Conditions: Hypercholesterolemia
Keywords: Cholesterol Ezetimibe
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 39
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare the effect on LDL cholesterol levels of converting patients who are receiving the cholesterol absorption inhibitor Zetia at a dose of 10 milligrams to 5 milligrams, when prescribed as a split 10 milligram tablet.

Detailed description:

Arms:
arm 1: A whole ezetimibe 10 mg tablet arm 2: Ezetimibe 5 mg, "formulated" by splitting a 10 mg ezetimibe tablet in half

Interventions: intervention 1: Ezetimibe 10 mg intervention 2: Ezetimibe 5 mg
Intervention descriptions: intervention 1: Ezetimibe 10 mg daily for 4 weeks intervention 2: Ezetimibe 5 mg daily for 4 weeks, "formulated" as a 10 mg tablet split in half

Protocol document: